SUPERRCA Trademark

Trademark Overview


On Friday, June 17, 2022, a trademark application was filed for SUPERRCA with the United States Patent and Trademark Office. The USPTO has given the SUPERRCA trademark a serial number of 97463374. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by Rarity Bioscience AB. The SUPERRCA trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for cancer diagnosis and prognosis; DNA screening for medical purposes; DNA analysis being sequence detection for cancer diagnosis and prognosis; providing information related to the care of persons, being information on medical testing services relating to the treatment of disease

Scientific research and development within biotechnology and medical technology; scientific research for medical purposes in the area of genetic analysis and mutation detection; DNA screening for scientific research purposes
superrca

General Information


Serial Number97463374
Word MarkSUPERRCA
Filing DateFriday, June 17, 2022
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7302448
Registration DateTuesday, February 13, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements


Pseudo MarkSUPER RCA
Goods and ServicesMedical services; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for cancer diagnosis and prognosis; DNA screening for medical purposes; DNA analysis being sequence detection for cancer diagnosis and prognosis; providing information related to the care of persons, being information on medical testing services relating to the treatment of disease
Goods and ServicesScientific research and development within biotechnology and medical technology; scientific research for medical purposes in the area of genetic analysis and mutation detection; DNA screening for scientific research purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 5, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 5, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRarity Bioscience AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUppsala 75237
SE

Party NameRarity Bioscience AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUppsala 75237
SE

Party NameRarity Bioscience AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUppsala 75237
SE

Trademark Events


Event DateEvent Description
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 31, 2023NON-FINAL ACTION E-MAILED
Thursday, August 31, 2023NON-FINAL ACTION WRITTEN
Thursday, August 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2023ASSIGNED TO LIE
Tuesday, April 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 19, 2023NON-FINAL ACTION E-MAILED
Thursday, January 19, 2023NON-FINAL ACTION WRITTEN
Wednesday, January 18, 2023ASSIGNED TO EXAMINER
Tuesday, July 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 21, 2022NEW APPLICATION ENTERED